Chemotherapy use among Medicare beneficiaries at the end of life.
about
Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental healthWithdrawal of anticancer therapy in advanced disease: a systematic literature reviewPatterns of colorectal cancer care in the United States and Canada: a systematic reviewDeath in the Digital Age: A Systematic Review of Information and Communication Technologies in End-of-Life CareMeasuring intensity of end of life care: a systematic reviewEnd-of-life care characteristics for young adults with cancer who die in the hospitalRetrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: a systematic review.Limiting treatment and shortening of life: data from a cross-sectional survey in Germany on frequencies, determinants and patients' involvement.Nationwide monitoring of end-of-life care via the Sentinel Network of General Practitioners in Belgium: the research protocol of the SENTI-MELC study.Limited impact of palliative chemotherapy on survival in advanced solid tumours in patients with poor performance status.Physician factors associated with discussions about end-of-life care.Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09).Determinants of medical expenditures in the last 6 months of lifeThe effect on survival of continuing chemotherapy to near death.Reducing cancer costs and improving quality through collaboration with payers: a proposal from the Florida society of clinical oncologyReview article: palliative care in gynecologic oncology.Use of chemotherapy at the end of life in Turkey.Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview studyHospice care and survival among elderly patients with lung cancerTime from last chemotherapy to death and its correlation with the end of life care in a referral hospitalTrends in receiving chemotherapy for advanced cancer patients at the end of lifeDrugs, cancer and end-of-life care: a case study of pharmaceuticalization?Depression and end-of-life care for patients with cancerEnd-of-life care for Medicare beneficiaries with cancer is highly intensive overall and varies widely.Impact of payment reform on chemotherapy at the end of life.Association of age, gender, and race with intensity of end-of-life care for Medicare beneficiaries with cancer.Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute.Is there a cost to poor communication in cancer care?: a critical review of the literature.Care of cancer patients at the end of life in a German university hospital: A retrospective observational study from 2014.Radiological exams on end-stage oncologic patients before hospice admission.Intensity of Medical Interventions between Diagnosis and Death in Patients with Advanced Lung and Colorectal Cancer: A CanCORS Analysis.Dartmouth Atlas: putting end-of-life care on the map but missing psychosocial detail"Well, I think there is great variation...": a qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancer.Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer.Population-based trends in systemic therapy use and cost for cancer patients in the last year of life.High-cost imaging in elderly patients with stage IV cancer.Racial and ethnic differences in end-of-life costs: why do minorities cost more than whites?Chemotherapy Use, Performance Status, and Quality of Life at the End of LifeDecision-making in patients with advanced cancer compared with amyotrophic lateral sclerosis.Palliative Chemotherapy Affects Aggressiveness of End-of-Life Care.
P2860
Q24569677-260FF2D0-D161-4BCC-8EF4-4E3CD642A023Q26777486-2D96DBDB-F3BE-4C82-BEF7-637648D024EDQ26863029-E866F2BC-41A9-41A3-BA14-6A65C6D01872Q27307672-3A9A07E8-92AD-4558-8B5D-0EDED8F56783Q28080642-B2F96EC2-1012-481C-8B71-D56A01551BFEQ30366014-7D76FA41-055F-4C53-8DA8-E56D31EE59D9Q30827101-48E8E690-1370-466B-96B2-9EB946DAB3C4Q31155087-676E41CE-C018-44A1-AECA-0B6545968DACQ33301951-D44C7B15-2BC1-478B-BB5A-E41180BC2B32Q33395825-90BCDD85-2269-433A-9A09-DD55D8290FD6Q33643038-13B9A9FC-FE07-439D-99E7-0584F6164842Q33913975-C00BB764-9E61-4B39-AD55-EA9D2BA78B8DQ34020805-AB13C6B0-EB2E-4C4F-B146-47A7A28CDAFEQ34026916-D3A6F545-50B4-44D4-B311-0F97014A71ADQ34114926-1F90F843-E158-465B-9C86-BAF3C4ADAB5DQ34156710-A43A4683-276A-4716-A1D8-24F7B1EDB893Q34586853-7E015E26-A144-49BA-B519-6DD64C30590AQ34760086-1EF8EB09-2BA7-4395-A120-530AA959C503Q35137030-CDFBDA0D-E497-4FE5-B773-274D2930E227Q35188889-DC2FF0DF-A6A9-4B8D-94B5-E7BFD82D726BQ35194689-BBA0EA25-5447-40FB-AD12-32407E7B7F36Q35223735-7F8974F4-EB64-49DC-A882-3801C4B1370BQ35237260-D68F4B36-F154-4559-92DA-37FBFB535C7BQ35916955-ACAD0E43-68F2-44F1-80C0-A4E00B23FD12Q35947730-9058FA19-F7B9-4177-987A-4338BC1785A7Q35964790-EDDFE87E-3455-4DE5-9677-00A0CFE34682Q36186962-4EEAD7B8-6C8D-4F13-9BF5-BCD996EDE200Q36275102-E7824EDE-B3D7-4A0A-B875-7F868027CA65Q36338117-B885D37E-1DF0-4066-B60C-FE6B87B02C3CQ36379661-389CB074-DA89-4AE4-971B-75111B6D3903Q36406881-14141407-FC45-487E-99B8-C2C280549C02Q36510023-AF0E3AC9-E423-4CBA-8C18-9E7A87567A3EQ36565670-A900DE3A-0275-47CE-9916-C75A5C8D645CQ36612331-D37D65DF-8B19-4935-9E22-2057AB7850A9Q36658837-2AB49640-73A8-4DAD-B7FD-9A9B5DCD317DQ36727374-2ED213E7-AB26-4C65-8DDA-DF7C6EC952D7Q36753600-8414F0B6-DD38-4E84-A02D-1FC4C51F73E9Q36790047-4E9D7C49-6A17-463A-909D-581A0603DF95Q36948493-EB9F5416-F374-4133-B0F1-D9C30859F9A8Q37017029-852CA82D-1096-48BA-B2F1-342A4FFCAE20
P2860
Chemotherapy use among Medicare beneficiaries at the end of life.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Chemotherapy use among Medicare beneficiaries at the end of life.
@en
Chemotherapy use among Medicare beneficiaries at the end of life.
@nl
type
label
Chemotherapy use among Medicare beneficiaries at the end of life.
@en
Chemotherapy use among Medicare beneficiaries at the end of life.
@nl
prefLabel
Chemotherapy use among Medicare beneficiaries at the end of life.
@en
Chemotherapy use among Medicare beneficiaries at the end of life.
@nl
P2093
P1476
Chemotherapy use among Medicare beneficiaries at the end of life.
@en
P2093
Arlene S Ash
Gail Gazelle
Norman G Levinsky
Olga Saynina
Yinong Young-Xu
P304
P356
10.7326/0003-4819-138-8-200304150-00011
P407
P577
2003-04-01T00:00:00Z